Clinical Trials
17 trialsNCT07602777 2026-05-22
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
GlaxoSmithKline
Phase 1/2 Not yet recruiting
NCT07585266 2026-05-13
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
GlaxoSmithKline
Phase 3 Not yet recruiting
NCT07570823 2026-05-06
A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sinocelltech Ltd.
Phase 3 Not yet recruiting
NCT07379047 2026-04-24
GISTAR-1
Ningbo Newbay Technology Development Co., Ltd
Phase 2/3 Not yet recruiting
NCT07459283 2026-03-10
The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
FindCure Biosciences (ZhongShan) Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06985576 2025-12-18
Long-term Study to Evaluate Safety and Persistence of GF-CART01
GenomeFrontier Therapeutics TW Co., Ltd.
Not yet recruiting
NCT06748872 2024-12-27
EPITOME-1015-I
Medigene AG
Phase 1 Not yet recruiting
NCT06699576 2024-11-21
ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma.
Hansoh BioMedical R&D Company
Phase 1 Not yet recruiting
NCT06500091 2024-07-15
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2 Not yet recruiting
NCT06412458 2024-05-14
IM83 Clinical Study of CAR-T Cell Therapy in Patients With Relapsed or Refractory Osteosarcoma
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase 1 Not yet recruiting
NCT06264505 2024-02-28
Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study
Power Life Sciences Inc.
Not yet recruiting
NCT05535283 2024-01-02
Assessing Clinical Trial Experiences of Patients With Osteosarcoma
Power Life Sciences Inc.
Not yet recruiting
NCT06070259 2023-10-06
Insights Into Participating in Studies for Bone Cancer
Power Life Sciences Inc.
Not yet recruiting
NCT06039046 2023-09-15
Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
Power Life Sciences Inc.
Not yet recruiting
NCT06029465 2023-09-08
Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT06029478 2023-09-08
Understanding Engagement Trends in Chondrosarcoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT05361954 2023-04-12
Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid Tumors
Sorrento Therapeutics, Inc.
Phase 1 Not yet recruiting